64/100B39.440
USD
-0.54
(-1.35%)
Market Closed
Last updated: · Delayed 15 min
Medline price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Medline's P/S ratio is 1.13: its market cap of 34.65B USD over revenue of 30.68B USD in the last twelve months.
- Today
- 1.13
- Average, 5 years
- 1.13
- Low, 5 years
- 0.90
- High, 5 years
- 1.43
P/S ratio = market cap ÷ revenue (last 12 months) = 34.65B ÷ 30.68B = 1.13
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 1.13 | 34.65B | 30.68B | |
| FY2025 | 31 Dec 2025 | 1.20 | 34.10B | 28.43B |
| FY2024 | 31 Dec 2024 | 1.27 | 32.27B | 25.51B |
| FY2023 | 31 Dec 2023 | 1.39 | 32.27B | 23.23B |
| FY2022 | 31 Dec 2022 | 1.50 | 32.27B | 21.45B |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 26 Sept 2026 | 0.99 | 30.41B | 30.68B |
| Q2 FY2026 | 27 Jun 2026 | 1.11 | 33.31B | 29.94B |
| Q1 FY2026 | 31 Mar 2026 | 1.25 | 36.45B | 29.14B |
| Q4 FY2025 | 31 Dec 2025 | 1.20 | 34.10B | 28.43B |
| Q3 FY2025 | 30 Sept 2025 | — | 32.27B | — |
| Q2 FY2025 | 30 Jun 2025 | — | 32.27B | — |
| Q1 FY2025 | 28 Mar 2025 | — | 32.79B | — |
| Q3 FY2024 | 30 Sept 2024 | — | 32.27B | — |
| Q2 FY2024 | 30 Jun 2024 | — | 32.27B | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Medline's P/S ratio
Source: Financial Modeling Prep